The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. (2020)
Attributed to:
BRAIN UK: accessing NHS tissue archives for neuroscience research (2015-2019)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers12071744
PubMed Identifier: 32629964
Publication URI: http://europepmc.org/abstract/MED/32629964
Type: Journal Article/Review
Volume: 12
Parent Publication: Cancers
Issue: 7
ISSN: 2072-6694